1. Home
  2. ELME vs CRBU Comparison

ELME vs CRBU Comparison

Compare ELME & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.02

Market Cap

191.9M

Sector

Real Estate

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.66

Market Cap

167.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
CRBU
Founded
1960
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.9M
167.6M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
ELME
CRBU
Price
$2.02
$1.66
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$12.67
$10.75
AVG Volume (30 Days)
1.0M
1.9M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
707.44%
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
$5.03
$1.63
Revenue Next Year
$4.31
$10.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$1.22
52 Week High
$17.68
$3.53

Technical Indicators

Market Signals
Indicator
ELME
CRBU
Relative Strength Index (RSI) 43.54 36.16
Support Level $1.98 $1.39
Resistance Level $2.06 $1.73
Average True Range (ATR) 0.03 0.13
MACD 0.00 -0.02
Stochastic Oscillator 16.67 14.66

Price Performance

Historical Comparison
ELME
CRBU

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: